Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group
- PMID: 25304610
- PMCID: PMC4281327
- DOI: 10.3324/haematol.2014.112151
Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group
Keywords: SIL/TAL1; acute lymphoblastic leukemia; children and adolescents.
Figures
References
-
- Cavè H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A, et al. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and SIL-TAL fusion in childhood T-Cell malignancies: results of EORTC studies 58881 and 58951. Blood. 2004;103(2):442–50. - PubMed
-
- Conter V, Aricò M, Basso G, Biondi A, Barisone E, Messina C, et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24(2):255–64. - PubMed
-
- Van Grotel M, Meijerink J, Beverloo HB, Langerak AW, Buys-Gladdines JG, Schneider P, et al. The outcome of molecular cytogenetic subgroups in pediatric T cell acute lymphoblastic leukemia; a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica. 2006;91(9):1212–21. - PubMed
-
- Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol. 2011;29(5):534–43. - PubMed
-
- La Starza R, Lettieri A, Pierini V, Nofrini V, Gorello P, Songia S, et al. Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia. Leuk Res. 2013;37(8):928–35. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
